Intelligent Bio Solutions Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Revenue	1.99	0.44	1.98	0.19	0
Revenue Growth (YoY)	356.25%	-77.93%	949.30%	100295.74%	-
Cost of Revenue	0.93	0	0	0	0
Gross Profit	1.06	0.44	1.98	0.19	0
Selling, General & Admin	8.03	4.92	3.72	2.46	3.52
Research & Development	0.51	3.85	3.84	0.59	3.18
Other Operating Expenses	5.13	0	0	0	0.03
Operating Expenses	13.66	8.77	7.55	3.05	6.73
Operating Income	-12.6	-8.34	-5.57	-2.86	-6.73
Interest Expense / Income	0.22	0.01	1.09	0.46	0.66
Other Expense / Income	-2.19	-0.04	0.37	-0.15	-0.06
Pretax Income	-10.63	-8.31	-7.04	-3.16	-7.34
Net Income	-10.63	-8.31	-7.04	-3.16	-7.34
Shares Outstanding (Basic)	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0
Shares Change	37.00%	40.81%	22.38%	1.52%	-
EPS (Basic)	-126.96	-135.96	-163.20	-88.80	-211.20
EPS (Diluted)	-126.96	-135.96	-163.20	-88.80	-211.20
Free Cash Flow	-7.88	-3.74	-11.3	-0.5	-5.58
Free Cash Flow Per Share	-94.16	-61.18	-260.31	-14.06	-159.68
Gross Margin	53.36%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-631.50%	-1907.11%	-281.42%	-1513.69%	-3579540.96%
Profit Margin	-533.05%	-1900.06%	-355.33%	-1676.23%	-3902492.55%
Free Cash Flow Margin	-395.21%	-855.15%	-570.39%	-264.18%	-2966587.23%
EBITDA	-9.44	-8.3	-5.94	-2.71	-6.67
EBITDA Margin	-473.37%	-1898.34%	-300.11%	-1433.70%	-3548854.26%
Depreciation & Amortization	0.97	0	0	0	0
EBIT	-10.41	-8.3	-5.94	-2.71	-6.67
EBIT Margin	-521.84%	-1898.34%	-300.11%	-1433.70%	-3548854.26%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).